U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 29 results

Status:
US Approved Rx (2019)
First approved in 1988

Class (Stereo):
CHEMICAL (ACHIRAL)



DOTAREM (Gadoterate Meglumine ) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associatedtissues in adult and pediatric patients (2 years of age and older) ...
Status:
US Approved Rx (1982)
First approved in 1966

Class (Stereo):
CHEMICAL (ACHIRAL)



Furosemide, a sulfonamide-type loop diuretic structurally related to bumetanide, is used to manage hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide inhibits wa...
Status:
US Approved Rx (2002)
First approved in 1954

Class (Stereo):
CHEMICAL (ABSOLUTE)



Digoxin, a cardiac glycoside similar to digitoxin, is used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. Digoxin inhibits...
Status:
Other

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

6-Aminonicotinamide is an inhibitor of the NADP+-dependent enzyme, 6-phosphogluconate dehydrogenase; it also interferes with glycolysis, resulting in ATP depletion. It was shown, that the combination of 6-aminonicotinamide with 2-deoxy-D-glucose indu...
Status:
US Approved Rx (2019)
First approved in 1988

Class (Stereo):
CHEMICAL (RACEMIC)



DOTAREM (Gadoterate Meglumine ) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associatedtissues in adult and pediatric patients (2 years of age and older) ...
Status:
US Approved Rx (2019)
First approved in 1988

Class (Stereo):
CHEMICAL (ACHIRAL)



DOTAREM (Gadoterate Meglumine ) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associatedtissues in adult and pediatric patients (2 years of age and older) ...
Status:
US Approved Rx (2019)
First approved in 1988

Class (Stereo):
CHEMICAL (ACHIRAL)



DOTAREM (Gadoterate Meglumine ) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associatedtissues in adult and pediatric patients (2 years of age and older) ...
Status:
US Approved Rx (2019)
First approved in 1988

Class (Stereo):
CHEMICAL (ACHIRAL)



DOTAREM (Gadoterate Meglumine ) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associatedtissues in adult and pediatric patients (2 years of age and older) ...
Status:
US Approved Rx (2019)
First approved in 1988

Class (Stereo):
CHEMICAL (ACHIRAL)



DOTAREM (Gadoterate Meglumine ) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associatedtissues in adult and pediatric patients (2 years of age and older) ...
Status:
US Approved Rx (2019)
First approved in 1988

Class (Stereo):
CHEMICAL (ACHIRAL)



DOTAREM (Gadoterate Meglumine ) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associatedtissues in adult and pediatric patients (2 years of age and older) ...